Table 7.
Comparison of Concomitant Diseases
Concomitant diseases | Ulcerative Colitis(%) N=454 | Crohn’s Disease(%) N=333 | p value |
---|---|---|---|
Yes | 393(86.6%) | 265(79.6%) | 0.009 |
With two or more | 333(73.3%) | 196(58.9%) | <0.001 |
Rheumatic diseases | 8(1.8%) | 19(5.7%) | 0.003 |
Hypertension | 108(23.8%) | 49(14.7%) | 0.002 |
Pulmonary nodules | 28(6.2%) | 14(4.2%) | 0.226 |
Cerebral infarction | 23(5.1%) | 12(3.6%) | 0.325 |
Diabetes | 35(7.7%) | 14(4.2%) | 0.044 |
Hyperlipidemia | 12(2.6%) | 8(2.4%) | 0.832 |
Osteoporosis | 27(5.9%) | 25(7.5%) | 0.384 |
Thyroid dysfunction | 14(3.1%) | 6(1.8%) | 0.259 |
Colorectal polyps | 95(20.9%) | 27(8.1%) | <0.001 |
Reflux esophagitis | 48(10.6%) | 17(5.1%) | 0.006 |
Peptic ulcer | 34(7.5%) | 30(9.0%) | 0.441 |
Fatty liver | 70(15.4%) | 43(12.9%) | 0.322 |
Autoimmune liver disease | 0(0.0%) | 1(0.3%) | 0.423 |
Old pulmonary tuberculosis | 20(4.4%) | 7(2.1%) | 0.079 |
Hepatitis B | 9(2.0%) | 9(2.7%) | 0.504 |
EB virus infection | 7(1.5%) | 23(6.9%) | <0.001 |
T-SPOT positive | 5(1.1%) | 5(1.5%) | 0.750 |
Upper gastrointestinal cancers | 1(0.2%) | 2(0.6%) | 0.787 |
Colorectal cancer | 9(2.0%) | 1(0.3%) | 0.051 |
Other tumors | 18(4.0%) | 16(4.8%) | 0.567 |